The Peripheral T‐Cell Lymphomas
About this book
The first text dedicated to peripheral T-cell lymphomas and their classification, diagnosis, and management
Peripheral T-cell lymphomas (PTCL) are a diverse group of lymphoid malignancies that develop from mature T cells and natural killer (NK) cells. PTCL represents 10-15% of all cases of non-Hodgkin lymphoma in the US, and up to 20-25% of cases in South America, Asia, and other regions around the world. The role of different etiologic factors and the variation of geographic distribution makes PTCL one of the most difficult types of cancer to understand and treat.
The first book of its kind, The Peripheral T-Cell Lymphomas presents a far-reaching survey of this complex and rare group of blood cancers. Featuring contributions from thought-leaders concerned with all aspects of PTCL, this authoritative text covers biology, epidemiology, classification, approved and emerging drugs, molecular genetics, and more. Detailed clinical chapters address diagnosis, prognosis, and treatment of each of the major PTCL subtypes identified in the 2018 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. This much-needed resource:
- Covers the biological basis, epidemiology, classification, and treatment of PTCL
- Discusses the future of the field, including global collaboration efforts and novel approaches to PCTL
- Explores the role of biologics in PTCL and autologous and allogeneic stem-cell transplantation
- Offers new insights on molecular pathogenesis, innovative therapeutics, and novel drug combinations
- Features contributions from the Chairs The T-Cell Lymphoma Forum: the world’s largest meeting focused on PTCL
Reflecting the unique epidemiology and genetic diversity of the PTCL, The Peripheral T-Cell Lymphomas is an indispensable source of data, insight, and references for the medical community, particularly those working in oncology and hematology.
Author Bios
Owen A. O’Connor, MD, PhD is American Cancer Society Research Professor, Professor of Medicine and Experimental Therapeutics, and Founding Director of the Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA.
Won Seog Kim, MD, PhD is Professor of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pier Luigi Zinzani, MD, PhD is Professor of Hematology, Director of Lymphoma and CLL Unit, and Chief of Phase I clinical trials, Institute of Hematology, University of Bologna, Bologna, Italy.